by Katie Stone and Gen Sander
Harm Reduction International (HRI), 2016
148 pp. 11.3 MB
Services to reduce drug-related harms are failing to keep up with growing need, despite pledges to combat AIDS among people who inject drugs The drive to scale-up needle and syringe programmes and opioid substitution therapy for people who inject drugs has stalled, according to this new report released by Harm Reduction International (HRI). Despite a UN pledge to end AIDS by 2030, no new countries have established needle and syringe programmes (NSP) since 2014. Out of 158 countries where injecting drug use is reported, 68 still do not provide NSP, while opioid substitution therapy (OST) has been initiated in just three new countries (Monaco, Senegal and Kenya), bringing the total to 80.